IFNB1 and prostate cancer: Based on these results, we concluded that HB1.F3.CD and HB1.F3.CD.IFN-β cells exert anti-tumor effects against prostate cancer cells, and the “double punch system” involving expression of CD and IFN-β genes has strong cytotoxic effects on the cancer cells.